T. Rowe Price Health Sciences I
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
Vitals
YTD Return
-17.6%
1 yr return
-9.4%
3 Yr Avg Return
13.5%
5 Yr Avg Return
12.7%
Net Assets
$15.7 B
Holdings in Top 10
35.6%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.65%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 33.80%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$500,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Investment Style
Health
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
THISX - Profile
Distributions
- YTD Total Return -17.6%
- 3 Yr Annualized Total Return 13.5%
- 5 Yr Annualized Total Return 12.7%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.10%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameT. Rowe Price Health Sciences Fund
-
Fund Family NameT. Rowe Price
-
Inception DateMar 23, 2016
-
Shares OutstandingN/A
-
Share ClassInst
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerZiad Bakri
Fund Description
The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.
THISX - Performance
Return Ranking - Trailing
| Period | THISX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -17.6% | -39.5% | 25.3% | 71.04% |
| 1 Yr | -9.4% | -60.2% | 33.9% | 56.28% |
| 3 Yr | 13.5%* | -10.0% | 19.7% | 28.19% |
| 5 Yr | 12.7%* | -6.4% | 16.9% | 7.69% |
| 10 Yr | 16.8%* | 6.4% | 18.5% | 2.38% |
* Annualized
Return Ranking - Calendar
| Period | THISX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | 5.2% | -79.9% | 25.9% | 38.25% |
| 2020 | 21.4% | -13.6% | 178.2% | 24.69% |
| 2019 | 21.5% | 3.8% | 63.8% | 42.07% |
| 2018 | -4.7% | -49.7% | 21.5% | 39.42% |
| 2017 | 19.1% | -59.8% | 54.4% | 49.63% |
Total Return Ranking - Trailing
| Period | THISX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -17.6% | -46.5% | 25.3% | 66.52% |
| 1 Yr | -9.4% | -60.2% | 31.1% | 59.01% |
| 3 Yr | 13.5%* | -15.9% | 20.0% | 30.56% |
| 5 Yr | 12.7%* | -7.4% | 16.9% | 8.62% |
| 10 Yr | 16.8%* | 6.4% | 18.5% | 2.21% |
* Annualized
Total Return Ranking - Calendar
| Period | THISX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | 5.2% | -79.9% | 25.9% | 38.25% |
| 2020 | 21.4% | -13.6% | 178.2% | 24.69% |
| 2019 | 21.5% | 3.8% | 63.8% | 42.07% |
| 2018 | -4.7% | -49.7% | 22.2% | 45.99% |
| 2017 | 19.1% | -59.8% | 54.4% | 60.00% |
NAV & Total Return History
THISX - Holdings
Concentration Analysis
| THISX | Category Low | Category High | THISX % Rank | |
|---|---|---|---|---|
| Net Assets | 15.7 B | 732 K | 46.2 B | 3.68% |
| Number of Holdings | 185 | 11 | 473 | 5.31% |
| Net Assets in Top 10 | 6.24 B | 2.18 K | 21.6 B | 2.86% |
| Weighting of Top 10 | 35.61% | 12.3% | 94.7% | 82.86% |
Top 10 Holdings
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
- Aggregate Miscellaneous Equity 8.64%
Asset Allocation
| Weighting | Return Low | Return High | THISX % Rank | |
|---|---|---|---|---|
| Stocks | 90.99% | 85.37% | 106.13% | 98.37% |
| Cash | 9.01% | -0.10% | 9.01% | 0.82% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 93.88% |
| Other | 0.00% | -22.99% | 3.38% | 88.98% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 92.24% |
| Bonds | 0.00% | 0.00% | 12.39% | 93.47% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | THISX % Rank | |
|---|---|---|---|---|
| Healthcare | 98.84% | 59.26% | 100.00% | 82.04% |
| Basic Materials | 0.94% | 0.00% | 14.83% | 8.57% |
| Financial Services | 0.22% | 0.00% | 1.85% | 9.80% |
| Utilities | 0.00% | 0.00% | 0.00% | 92.24% |
| Technology | 0.00% | 0.00% | 22.69% | 92.65% |
| Real Estate | 0.00% | 0.00% | 7.13% | 93.06% |
| Industrials | 0.00% | 0.00% | 7.02% | 93.06% |
| Energy | 0.00% | 0.00% | 0.00% | 92.24% |
| Communication Services | 0.00% | 0.00% | 9.11% | 92.24% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 93.88% |
| Consumer Cyclical | 0.00% | 0.00% | 14.20% | 93.06% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | THISX % Rank | |
|---|---|---|---|---|
| US | 81.31% | 53.67% | 104.41% | 67.76% |
| Non US | 9.68% | 0.00% | 45.40% | 54.69% |
THISX - Expenses
Operational Fees
| THISX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.65% | 0.08% | 3.13% | 58.54% |
| Management Fee | 0.63% | 0.00% | 1.25% | 47.89% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | 5.56% |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| THISX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 0.00% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| THISX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| THISX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 33.80% | 0.00% | 238.00% | 35.53% |
THISX - Distributions
Dividend Yield Analysis
| THISX | Category Low | Category High | THISX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 3.95% | 94.38% |
Dividend Distribution Analysis
| THISX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Semi-Annually | Monthly | Semi-Annually |
Net Income Ratio Analysis
| THISX | Category Low | Category High | THISX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.10% | -2.54% | 1.92% | 45.14% |
Capital Gain Distribution Analysis
| THISX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually |
THISX - Fund Manager Analysis
Managers
Ziad Bakri
Start Date
Tenure
Tenure Rank
Apr 01, 2016
6.17
6.2%
Ziad Bakri joined T. Rowe Price in 2011 and has since been a key member of the healthcare research team, influencing investment decisions and making significant contributions to the stock selections. Ziad has had a long track record of analyzing biotechnology companies, a key sector within the healthcare industry. Ziad brings a unique perspective to his new role, having been a medical doctor and an emergency medicine resident at the Royal London Hospital before beginning his investment career. Prior to joining T. Rowe Price, Ziad held biotechnology equity research and healthcare investment ban
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 6.48 | 2.12 |